住友ファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/09/02 | 1,590 | 1,689 | 1,581 | 1,633 | +68 | +4.3% | 12,334,700 |
2025/09/01 | 1,508 | 1,577 | 1,506 | 1,565 | +40 | +2.6% | 6,317,300 |
2025/08/29 | 1,486 | 1,550 | 1,481 | 1,525 | +35 | +2.3% | 5,831,300 |
2025/08/28 | 1,513 | 1,525 | 1,485 | 1,490 | -28 | -1.8% | 4,757,400 |
2025/08/27 | 1,516 | 1,551 | 1,508 | 1,518 | +7 | +0.5% | 7,312,500 |
2025/08/26 | 1,495 | 1,534 | 1,458 | 1,511 | +8 | +0.5% | 7,521,800 |
2025/08/25 | 1,512 | 1,539 | 1,495 | 1,503 | +63 | +4.4% | 8,597,100 |
2025/08/22 | 1,425 | 1,454 | 1,407 | 1,440 | +33 | +2.3% | 6,833,200 |
2025/08/21 | 1,383 | 1,444 | 1,380 | 1,407 | +26 | +1.9% | 8,044,700 |
2025/08/20 | 1,415 | 1,457 | 1,370 | 1,381 | -4 | -0.3% | 7,552,000 |
2025/08/19 | 1,366 | 1,390 | 1,343 | 1,385 | +9 | +0.7% | 4,143,100 |
2025/08/18 | 1,382 | 1,432 | 1,374 | 1,376 | -4 | -0.3% | 5,904,900 |
2025/08/15 | 1,358 | 1,383 | 1,347 | 1,380 | +31 | +2.3% | 4,298,400 |
2025/08/14 | 1,390 | 1,392 | 1,341 | 1,349 | -41 | -2.9% | 4,623,000 |
2025/08/13 | 1,401 | 1,416 | 1,383 | 1,390 | -6 | -0.4% | 6,868,500 |
2025/08/12 | 1,362 | 1,419 | 1,345 | 1,396 | +46 | +3.4% | 10,580,100 |
2025/08/08 | 1,340 | 1,370 | 1,325 | 1,350 | +10 | +0.7% | 8,871,500 |
2025/08/07 | 1,260 | 1,343 | 1,234 | 1,340 | +74 | +5.8% | 12,414,200 |
2025/08/06 | 1,317 | 1,333 | 1,265 | 1,266 | -50 | -3.8% | 13,345,400 |
2025/08/05 | 1,278 | 1,375 | 1,243 | 1,316 | +62 | +4.9% | 21,060,500 |
2025/08/04 | 1,213 | 1,258 | 1,190 | 1,254 | +18 | +1.5% | 9,491,900 |
2025/08/01 | 1,322 | 1,338 | 1,229 | 1,236 | -88 | -6.6% | 17,228,400 |
2025/07/31 | 1,317 | 1,359 | 1,306 | 1,324 | +2 | +0.2% | 14,911,800 |
2025/07/30 | 1,225 | 1,334 | 1,218 | 1,322 | +185 | +16.3% | 23,294,700 |
2025/07/29 | 1,125 | 1,146 | 1,120 | 1,137 | ±0 | ±0% | 3,636,400 |
2025/07/28 | 1,155 | 1,164 | 1,130 | 1,137 | -9 | -0.8% | 4,958,600 |
2025/07/25 | 1,135 | 1,148 | 1,105 | 1,146 | +11 | +1% | 5,994,200 |
2025/07/24 | 1,120 | 1,135 | 1,094 | 1,135 | +30 | +2.7% | 7,720,100 |
2025/07/23 | 1,051 | 1,106 | 1,050 | 1,105 | +68 | +6.6% | 8,091,300 |
2025/07/22 | 1,073 | 1,085 | 1,035 | 1,037 | -54 | -4.9% | 6,042,200 |
2025/07/18 | 1,099 | 1,122 | 1,070 | 1,091 | +21 | +2% | 10,104,700 |
2025/07/17 | 1,010 | 1,070 | 1,006 | 1,070 | +49 | +4.8% | 7,118,300 |
2025/07/16 | 1,003 | 1,023 | 988 | 1,021 | +5 | +0.5% | 4,731,400 |
2025/07/15 | 1,040 | 1,053 | 1,008 | 1,016 | -16 | -1.6% | 5,801,100 |
2025/07/14 | 1,004 | 1,035 | 990 | 1,032 | +19 | +1.9% | 5,246,500 |
2025/07/11 | 1,000 | 1,029 | 988 | 1,013 | +19 | +1.9% | 7,271,600 |
2025/07/10 | 973 | 1,015 | 962 | 994 | +17 | +1.7% | 9,846,300 |
2025/07/09 | 935 | 989 | 925 | 977 | +70 | +7.7% | 13,926,400 |
2025/07/08 | 949 | 949 | 886 | 907 | +1 | +0.1% | 12,523,600 |
2025/07/07 | 910 | 913 | 885 | 906 | +11 | +1.2% | 3,082,400 |
2025/07/04 | 893 | 905 | 877 | 895 | +5 | +0.6% | 4,009,800 |
2025/07/03 | 892 | 907 | 883 | 890 | -13 | -1.4% | 4,047,700 |
2025/07/02 | 913 | 916 | 891 | 903 | -29 | -3.1% | 5,368,500 |
2025/07/01 | 980 | 981 | 932 | 932 | -39 | -4% | 4,677,500 |
2025/06/30 | 1,006 | 1,009 | 962 | 971 | -12 | -1.2% | 8,664,700 |
2025/06/27 | 930 | 1,004 | 930 | 983 | +61 | +6.6% | 12,404,300 |
2025/06/26 | 931 | 946 | 917 | 922 | -15 | -1.6% | 4,132,800 |
2025/06/25 | 950 | 956 | 927 | 937 | -11 | -1.2% | 4,465,300 |
2025/06/24 | 970 | 971 | 940 | 948 | -3 | -0.3% | 4,818,300 |
2025/06/23 | 966 | 968 | 938 | 951 | -30 | -3.1% | 4,626,500 |
1~
50
件表示中 / 3775件
類似銘柄と比較する
現在ご覧いただいている「住友ファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
住友ファーマ | 163,300円 | -11.0% | +206.6% | 0.00% | 16.22倍 | 3.83倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
エーザイ | 468,400円 | +0.1% | -3.4% | 3.42% | 31.84倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 170,700円 | +0.6% | +43.3% | 4.69% | 11.97倍 | 1.03倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 255,600円 | +8.4% | +6.4% | 1.64% | 18.34倍 | 2.22倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 160,000円 | -2.0% | -7.3% | 2.38% | 15.64倍 | 1.86倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
市場注目の銘柄
チャート関連のコラム